Initiation of hepatic stellate cell activation extends into chronic liver disease
Abstract Activated hepatic stellate cells (aHSC) are the main source of extra cellular matrix in liver fibrosis. Activation is classically divided in two phases: initiation and perpetuation. Currently, HSC-based therapeutic candidates largely focus on targeting the aHSCs in the perpetuation phase. H...
Main Authors: | Vincent De Smet, Nathalie Eysackers, Vincent Merens, Mina Kazemzadeh Dastjerd, Georg Halder, Stefaan Verhulst, Inge Mannaerts, Leo A. van Grunsven |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-11-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-021-04377-1 |
Similar Items
-
Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases
by: Stefaan Verhulst, et al.
Published: (2021-10-01) -
Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29.
by: Inge Mannaerts, et al.
Published: (2013-01-01) -
Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration.
by: Inge Mannaerts, et al.
Published: (2013-01-01) -
The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
by: Joeri eLambrecht, et al.
Published: (2015-07-01) -
Improved Precision-Cut Liver Slice Cultures for Testing Drug-Induced Liver Fibrosis
by: Liza Dewyse, et al.
Published: (2022-03-01)